Cargando…
Are we doing the right surgical trials?: the difficult nature of ‘true’ equipoise
Cite this article: Bone Joint Res 2023;12(6):372–374.
Autores principales: | Makaram, Navnit S., Lamb, Sallie E., Simpson, A. Hamish R. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Editorial Society of Bone & Joint Surgery
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248536/ https://www.ncbi.nlm.nih.gov/pubmed/37287314 http://dx.doi.org/10.1302/2046-3758.126.BJR-2023-0154 |
Ejemplares similares
-
Disease-modifying agents in osteoarthritis: where are we now and what does the future hold?
por: Makaram, Navnit S., et al.
Publicado: (2023) -
Equipoise and the technology curve: Relevance in the design of Surgical trials
por: Simpson, A. H. R. W., et al.
Publicado: (2016) -
Glycemic equipoise
por: Kalra, Sanjay, et al.
Publicado: (2017) -
What to do with the equipoise?
por: Knol, Wiebe G, et al.
Publicado: (2019) -
What do we talk about when we talk about “equipoise”? Stakeholder interviews assessing the use of equipoise in clinical research ethics
por: Dewar, Brian, et al.
Publicado: (2023)